CARINA CARDILLO: Open Payments
NPI 1215476098 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 48 payments from 14 companies in 2025. Trend: 2023 $1,165 · 2024 $1,227 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $184 |
| Phathom Pharmaceuticals, Inc. | 11 | $122 |
| Ardelyx, Inc. | 5 | $102 |
| GENZYME CORPORATION | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: DUPIXENT, VOQUEZNA, IBSRELA, MAVYRET, IQIRVO, RINVOQ, ENTYVIO, XIFAXAN.
Industry payments across VA — which companies pay providers there.
